Whole-genome sequence analysis of the naturally competent Acinetobacter baumannii clinical isolate A118

Genome Biology and Evolution

Volumn 6, Issue 9, 2014, Pages 2235-2239

  Traglia, German M ^a   Chua, Katherina ^a   Centron, Daniela ^a   Tolmasky, Marcelo E ^b   Ramírez, María Soledad ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Acinetobacter baumannii; Genome analysis; SNPs

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; BACTERIAL GENOME; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GENOMICS; HUMAN; MICROBIOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; GENOME, BACTERIAL; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 84925488059     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evu176     Document Type: Article

References (18)

1. Adams MD, et al. 2009. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 53(9):3628-3634.
2. Aziz RK, et al. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75.
3. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5(6):e11147.
4. Delcher AL, et al. 1999. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27(23):4636-4341.
5. Hornsey M, et al. 2011. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother. 66(7):1499-1503.
6. Iacono M, et al. 2008. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother. 52(7):2616-2625.
7. Lowe TM, Eddy SR. 1997. TRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25(5):955-964.
8. McConnell MJ, Actis L, Pachon J. 2013. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 37(2):130-155.
9. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 21(3):538-582.
10. Perez F, et al. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 51(10):3471-3484.
11. Ramirez MS, et al. 2010. Naturally competent Acinetobacter baumannii clinical isolate as a convenient model for genetic studies. J Clin Microbiol. 48(4):1488-1490.
12. Ramirez MS, et al. 2011. Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype. Antimicrob Agents Chemother. 55(4):1520-1526.
13. Roca I, et al. 2012. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 3:148.
14. Sahl JW, et al. 2013. Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter. PLoS One 8(1):e54287.
15. Smith MG, et al. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21(5):601-614.
16. Snitkin ES, et al. 2011. Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proc Natl Acad Sci USA. 108(33):13758-13763.
17. Tan SY, et al. 2013. Comparative genomic analysis of rapid evolution of an extreme-drug-resistant Acinetobacter baumannii clone. Genome Biol Evol. 5(5):807-818.
18. Wilharm G, Piesker J, Laue M, Skiebe E. 2013. DNA uptake by the nosocomial pathogen Acinetobacter baumannii occurs while moving along wet surfaces. J Bacteriol. 195(18):4146-4153.